<DOC>
	<DOCNO>NCT01199523</DOCNO>
	<brief_summary>The objective study evaluate effect repeat oral dose mirabegron ECG ( electrocardiogram ) measurement .</brief_summary>
	<brief_title>A Study Evaluate Effect Oral Mirabegron Heart Healthy Males Females</brief_title>
	<detailed_description>Each subject randomize participate two 10-day treatment period daily dose mirabegron mirabegron/moxifloxacin placebo moxifloxacin moxifloxacin/mirabegron placebo occur follow 1-day post-treatment period . Each treatment period separate washout period least 12 day last dose study drug Day 10 Period 1 Day -4 Period 2 .</detailed_description>
	<mesh_term>Mirabegron</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>The subject must weigh least 45 kg body mass index ( BMI ) 20.0 28.5 kg/m2 , inclusive The female subject must postmenopausal ( define least 2 year without menses ) surgically sterile ( least 1 month prior screen ) . All woman child bear potential require use adequate contraception consist two form birth control ( one must barrier method ) , must lactate , must breastfeed study period 30 day final study drug administration . All woman childbearing potential must negative serum pregnancy test . Male subject female spouses/partners childbearing potential must use contraception consist two form birth control ( one must barrier method ) study period 30 day final study drug administration . The subject must negative test result drug abuse alcohol screen The subject must good venous access The subject know hypersensitivity mirabegron , adrenoreceptor agonist , constituent formulation use , moxifloxacin member quinolone class antimicrobial agent The subject history syncope , cardiac arrest , cardiac arrhythmia torsade de pointes , structural heart disease , valvular abnormality , family history long QT syndrome The subject experience acute febrile illness within past 7 day The subject history tendonitis and/or liver function abnormality relate quinolone antibiotic treatment The subject hyperthyroid disorder The subject history presence psychiatric illness , medical condition disorder may compromise evaluation drug effect , incapable compliant study procedures The subject donate lose â‰¥ 450 mL blood within 56 day prior study drug administration donate plasma within 7 day prior study drug administration The subject receive anticipated receive prescription drug within 14 day prior Day 4 Period 1 ( within 30 day prior Day 4 Period 1 long act treatment depot formulation ) . Subject take overthecounter ( OTC ) medication , include complementary alternative medicine ( except hormonal contraceptive include depot formulation , hormone replacement therapy occasional use acetaminophen 2000 mg/day 4 day per week ) within 14 day prior Day 4 Period 1 The subject consume alcohol , xanthine derivativecontaining food/beverages ( tea , chocolate ) , grapefruit juice , grapefruitcontaining product Seville orange ( e.g. , bitter marmalade ) within 48 hour admission unit Day 4 Period 1 The subject recent history alcohol substance abuse history alcohol substance dependence ( exception nicotine ) . The subject consumes 5 unit alcoholic beverage per week The subject use tobaccocontaining product nicotinecontaining product within 6 month The subject currently participate another clinical trial take take investigational drug 30 day 10 half life ( whichever longer ) , prior first study drug administration The subject know hepatitis human immunodeficiency virus ( HIV ) 1 and/or HIV2 , positive hepatitis A antibody IgM , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus ( HCV ) antibody The subject skin condition likely interfere electrocardiographic electrode placement adhesion The subject breast implant history thoracic surgery likely cause abnormality electrical conduction thoracic tissue The subject unable tolerate control , quiet study conduct environment , include avoidance specify time ( e.g. , ECG monitoring day ) music , TV , movie , game activity may cause excitement , emotional tension arousal The subject unwilling comply study rule , include attempt void restrict time ( e.g. , prior ECG extraction window ) , remain quiet , awake , undistracted , motionless supine specify time , avoid vigorous exercise direct</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>YM178</keyword>
	<keyword>Mirabegron</keyword>
	<keyword>QT</keyword>
</DOC>